	Effects of neoadjuvant novel endocrine therapy combined with prostatic artery embolization on SII, PNI, and bRFS in patients with prostate cancer. Am J Transl Res Zhao B, Li B, Jiang J, Ma Q, Zhang H, You J, Li K. PMID: 42170485 [PubMed]
	A case report of rectal squamous cell carcinoma following radiation therapy for prostate cancer: a management dilemma. J Gastrointest Oncol Nwokeocha SO, Kumar J, Soni R, Shah S, Patel AV. PMID: 42169951 [PubMed]
	A cohort study investigating differences in skeletal muscle mitochondrial function between prostate cancer patients and healthy controls. BMC Cancer Smart TF, Bass JJ, Crossland H, Cox J, Atherton PJ, Lund JN, Phillips BE. PMID: 42168935 [PubMed - as supplied by publisher]
	Robotics Is Not Important Because It Is Robotic: Re: Jeremy Y. Teoh, Francesco M. Bracco, Julius H. Wong, et al. A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial. Eur Urol Oncol 2026;86:111-15. Eur Urol Oncol Güven S, Soyturk S, Herrmann T. PMID: 42168051 [PubMed - as supplied by publisher]
	Reply to Daoyuan Li's Words of Wisdom re: Bacillus Calmette-GuÃ©rin Plus Mitomycin Versus Bacillus Calmette-GuÃ©rin Alone for Bacillus Calmette GuÃ©rin-naÃ¯ve Non-Muscle-Invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.011. Eur Urol Hayne D, Zhang AY, Thomas H, Redfern AD, Davis ID, Stockler MR. PMID: 42168001 [PubMed - as supplied by publisher]
	Impact of intraoperative intravenous heparin bolus on clinical outcomes during radical nephrectomy and IVC tumor thrombectomy in renal cell carcinoma with level I-IV IVC thrombus: A multi-institutional study. Urol Oncol Aydin AM, Dehghanmanshadi A, Mukhtar V, Siegel ER, Moon S, Biben E, Patel K, Kuykendall K, Fang AM, Langford T, Gokden N, Chang D, Kwon D, Ferguson JE, Peyton CC. PMID: 42167989 [PubMed - as supplied by publisher]
	Is Perirenal Fat an Active Player in Renal Cell Carcinoma Tumorigenesis? A Radiologic-Pathologic Correlation Study. Fr J Urol Gökkurt Y, Karakan T, Kesero, Bayburtluo, Demir DÖ, Y, Kaçan T. PMID: 42167716 [PubMed - as supplied by publisher]
	A DNA Methylation-based algorithm Improves Lung Cancer risk prediction in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Lung Cancer Dawes K, Mills JA, Hoffman RM, Froehlich EM, deBlois K, Sieren JC, Williams C, Merkle S, Long JD, Beach SR, Philibert RA. PMID: 42167026 [PubMed - as supplied by publisher]
	Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer. J Clin Oncol Murthy V, Maitre P, Pal M, Arora A, Phurailatpam R, Sharma R, Gudipudi D, Rajappa S, Pujari L, Bandekar B, Joseph D, Kannan S, Krishnatry R, Misra A, Joshi A, Noronha V, Prabhash K, Menon S, Bakshi G, Prakash G. PMID: 42166701 [PubMed - as supplied by publisher]
	Disparities in prostate cancer screening practices among general practitioners and urologists (PROSHADE study): A cross-sectional study. PLoS One Lumbreras B, Parker LA, Alonso-Coello P, Caballero-Romeu JP, Párraga-Martínez I, Prieto L, Moral-Peláez I, Del Campo-Giménez M, Gómez-Pérez L, Cebrián A, López-Garrigós M, Ronda E, Guilabert M, Canelo-Aybar C, Hernández-Aguado I. PMID: 42166422 [PubMed - indexed for MEDLINE]
	Tubulocystic Renal Cell Carcinoma: A Scoping Review of Radiological, Clinicopathological, and Immunohistochemical Features. Urol Int AbuHaweeleh MN, Alhyari A, Abuhayeh N, Emam F, Al-Qudimat AR, Al Rumaihi K, Khalil IA. PMID: 42166387 [PubMed - as supplied by publisher]
	Axitinib-Pembrolizumab and Adverse Event Management in Patients With Advanced Renal Cell Carcinoma. JAMA Netw Open Shah NJ, Ababio Y, Eccleston A, Rao D, Kelly SP, Chang J, Lucht S, Paydar C, Van Doren BA, Bland E, John W, Giegerich S, Laney J, Feinberg B, Zarrabi KK. PMID: 42166160 [PubMed - indexed for MEDLINE]
	Androgen Receptor Expression in Urothelial Bladder Cancer-A Systematic Review and Meta-Analysis. ANZ J Surg Buckby A, Gholami M, Hong M, O'Callaghan M. PMID: 42165524 [PubMed - as supplied by publisher]
	Treatment and progression of patients in Sweden with metastatic castration-sensitive prostate cancer. Acta Oncol Styrke J, Jellvert Å, Hjälm Eriksson M, Sandin F, Axén E, Jabbar S, Juhl Norgaard K. PMID: 42165189 [PubMed - indexed for MEDLINE]
	Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery. Eur Urol Open Sci Tazawa S, Shinohara M, Kawashima Y, Sekine Y, Narita S, Kobayashi S, Abe N, Narita T, Fujita N, Mikami J, Okamoto T, Yamamoto H, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S. PMID: 42164551 [PubMed]
	The role of CD36 in renal and bladder cancer. Discoveries (Craiova) Pavalean MI, Madan VL, Pavalean MC, Ceafalan LC, Hinescu ME. PMID: 42164471 [PubMed]
	Meta-analysis of efficacy comparisons between standard- and low-dose Bacillus Calmette-Guerin vaccines in managing non-muscular invasive bladder cancer. Oncol Lett Liu X, Bao Y. PMID: 42164465 [PubMed]
	Bioinformatics analysis and experimental approach identify BRD-family gene DSP as a diagnostic and prognostic indicator in bladder cancer. Transl Androl Urol Liu Z, Tan T, Li S, Wang Y. PMID: 42164400 [PubMed]
	Advancing bladder cancer detection: commentary on a urinary DNA methylation diagnostic assay. Transl Androl Urol Duquesne I, Chakra MA, Myers AA, Boormans JL, Hayne D, Brown JA, O'Donnell MA. PMID: 42164398 [PubMed]
	Oncologic outcomes of transurethral resection versus laser excision for non-muscle invasive bladder cancer: a SEER retrospective cohort study. Transl Androl Urol Xia Y, Ma B, Huang T, Liu X. PMID: 42164394 [PubMed]

Articles 1 - 20 / 178420

Page 1 of 8921



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy